doi:10.1001/jama.2015.9676 Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al
Am J Reprod Immunol (New York N.Y.: 1989)
Theoretically, the two compounds target completely different receptor systems (amylin receptors for cagrilintide, GLP-1/GIP/glucagon for retatrutide), which suggests they could work synergistically without receptor overlap
In the Cagrilintide vs Retatrutide side effect comparison, Cagrilintide generally has lower vomiting rates
For example, if your target is 1,000mg, you could take 500mg in the morning and 500mg in the afternoon